Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Peter Hartung

Showing results (11-20 of 601) with videos related to

Pageof 61
Sort By:
Archives of Neurology|March 14, 2012
Volume transmission-mediated encephalopathies: a possible new concept?Hans-Peter Hartung, Marcel Dihné
Expert Review of Clinical Pharmacology|December 12, 2013
Novel therapeutic options for multiple sclerosisFrançois Curtin, Hans-Peter Hartung
Progress in Neurobiology|January 18, 2003
Remyelinating strategies for the treatment of multiple sclerosisMartin Stangel, Hans-Peter Hartung
Expert Review of Neurotherapeutics|May 12, 2007
Evaluation of atorvastatin and simvastatin for treatment of multiple sclerosisOliver Neuhaus, Hans-Peter Hartung
Therapeutic Advances in Neurological Disorders|December 24, 2010
Atacicept: targeting B cells in multiple sclerosisHans-Peter Hartung, Bernd C Kieseier
Seminars in Neurology|August 2, 2003
Therapeutic strategies in the Guillain-Barré syndromeBernd C Kieseier, Hans-Peter Hartung
Seminars in Neurology|August 2, 2003
Current disease-modifying therapies in multiple sclerosisBernd C Kieseier, Hans-Peter Hartung
Journal of Neuroimmunology|November 9, 2010
Plasma exchange and intravenous immunoglobulins: mechanism of action in immune-mediated neuropathiesHelmar C Lehmann, Hans-Peter Hartung
Experimental Neurology|January 29, 2013
Targeting two-pore domain potassium channels - a promising strategy for treating T cell mediated autoimmunityBernd C Kieseier, Hans-Peter Hartung
Current Opinion in Neurology|July 15, 2003
Multiple paradigm shifts in multiple sclerosisBernd C Kieseier, Hans-Peter Hartung
Pageof 61

Showing results (11-20 of 601) with videos related to

Sort By:
Pageof 61
Archives of Neurology|March 14, 2012
Volume transmission-mediated encephalopathies: a possible new concept?Hans-Peter Hartung, Marcel Dihné
Expert Review of Clinical Pharmacology|December 12, 2013
Novel therapeutic options for multiple sclerosisFrançois Curtin, Hans-Peter Hartung
Progress in Neurobiology|January 18, 2003
Remyelinating strategies for the treatment of multiple sclerosisMartin Stangel, Hans-Peter Hartung
Expert Review of Neurotherapeutics|May 12, 2007
Evaluation of atorvastatin and simvastatin for treatment of multiple sclerosisOliver Neuhaus, Hans-Peter Hartung
Therapeutic Advances in Neurological Disorders|December 24, 2010
Atacicept: targeting B cells in multiple sclerosisHans-Peter Hartung, Bernd C Kieseier
Seminars in Neurology|August 2, 2003
Therapeutic strategies in the Guillain-Barré syndromeBernd C Kieseier, Hans-Peter Hartung
Seminars in Neurology|August 2, 2003
Current disease-modifying therapies in multiple sclerosisBernd C Kieseier, Hans-Peter Hartung
Journal of Neuroimmunology|November 9, 2010
Plasma exchange and intravenous immunoglobulins: mechanism of action in immune-mediated neuropathiesHelmar C Lehmann, Hans-Peter Hartung
Experimental Neurology|January 29, 2013
Targeting two-pore domain potassium channels - a promising strategy for treating T cell mediated autoimmunityBernd C Kieseier, Hans-Peter Hartung
Current Opinion in Neurology|July 15, 2003
Multiple paradigm shifts in multiple sclerosisBernd C Kieseier, Hans-Peter Hartung
Pageof 61